VALIANT Phase 3 data in nephrology after presentation at the ERA congress. STOCKHOLM, June 3, 2025 /PRNewswire/ -- Investors, analysts, and members of the media are invited to a conference call on Thursday, 12 June, at 13:30 CEST, 12:30 GMT, and 08:30 EDT. The call will include a...
Read More Details
Finally We wish PressBee provided you with enough information of ( Invitation: Sobi's Aspaveli® - 52-week Phase 3 VALIANT data in nephrology )
Also on site :